Fusion Antibodies (FAB)

Sector:

Health Care

Index:

FTSE AIM All-Share

6.00p
   
  • Change Today:
    -0.45p
  • 52 Week High: 19.25
  • 52 Week Low: 5.50
  • Currency: UK Pounds
  • Shares Issued: 125.16m
  • Volume: 897,525
  • Market Cap: £7.51m
  • RiskGrade: 464

FAB Overview

Fusion Antibodies is a Collaborative Research Organisation (CRO) with its headquarters in Northern Ireland. We are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics through to clinical Cell Line Development.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -53.7% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.9 n/a
Pr/Book 8.9  
Latest F'cast
Revenue 7.4% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

FAB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-22 4.80 (1.33) (4.60)p n/a n/a n/a n/a 0.0%
31-Mar-23 2.90 (2.86) (10.00)p n/a n/a n/a n/a 0.0%
31-Mar-24 1.14 (2.29) (3.90)p n/a n/a n/a n/a 0.0%
31-Mar-25 1.97 (1.63) (1.70)p n/a n/a n/a n/a 0.0%
31-Mar-26 2.11 (1.15) (1.20)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

FAB Company Announcements

Result of AGM 15-Oct-2026 13:20 RNS
AGM statement H1 trading and research update 15-Oct-2026 07:00 RNS
Posting of Annual Report & Notice of AGM 22-Sep-2026 07:00 RNS

FAB ShareCast News

Fusion Antibodies reports progress with DR5 proj... 15-Jun-2026 ShareCast
Fusion Antibodies upbeat on 'mixed but improving... 05-May-2026 ShareCast
Fusion Antibodies enters deal to transfer IP to ... 30-Mar-2026 ShareCast

Latest FAB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

FAB Market Data

Currency UK Pounds
Share Price 6.00p
Change Today -0.45p
% Change -6.98 %
52 Week High 19.25
52 Week Low 5.50
Volume 897,525
Shares Issued 125.16m
Market Cap £7.51m
RiskGrade 464

FAB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.76% below the market average34.76% below the market average34.76% below the market average34.76% below the market average34.76% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Price Trend
50.73% above the market average50.73% above the market average50.73% above the market average50.73% above the market average50.73% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average
Income Not Available
Growth
27.56% above the market average27.56% above the market average27.56% above the market average27.56% above the market average27.56% above the market average
7.14% below the sector average7.14% below the sector average7.14% below the sector average7.14% below the sector average7.14% below the sector average

FAB Dividends

No dividends found

Trades for 19-Oct-2026

Time Volume / Share Price
16:13 20,000 @ 5.82p
15:51 20,000 @ 5.82p
14:20 30,000 @ 6.17p
14:15 25,000 @ 6.00p
14:15 600 @ 6.10p

FAB Key Personnel

Chair Simon Gordon Douglas
CEO Adrian Kinkaid

Top of Page